Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Hepatitis C, Chronic blood"" wg kryterium: Temat


Wyświetlanie 1-15 z 15
Tytuł :
Secretion of Hepatitis C Virus Replication Intermediates Reduces Activation of Toll-Like Receptor 3 in Hepatocytes
Autorzy :
Grünvogel, Oliver
Colasanti, Ombretta
Lee, Ji-Young
Klöss, Volker
Belouzard, Sandrine
Reustle, Anna
Esser-Nobis, Katharina
Hesebeck-Brinckmann, Jasper
Mutz, Pascal
Hoffmann, Katrin
Mehrabi, Arianeb
Koschny, Ronald
Vondran, Florian W.R.
Gotthardt, Daniel
Schnitzler, Paul
Neumann-Haefelin, Christoph
Thimme, Robert
Binder, Marco
Bartenschlager, Ralf
Dubuisson, Jean
Dalpke, Alexander
Lohmann, Volker
Pokaż więcej
Temat :
MESH: RNA, Viral/metabolism
Rab27a
MESH: Hepacivirus/physiology
MESH: Primary Cell Culture
MESH: Immunity, Innate
MESH: Interferons/metabolism
MESH: Hepatocytes/immunology
MESH: RNA, Viral/immunology
MESH: Hepatocytes/metabolism
MESH: RNA, Double-Stranded/isolation & purification
[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology
Exosomes
MESH: Hepatitis C, Chronic/immunology
Escape
MESH: Cell Line
MESH: RNA, Double-Stranded/metabolism
MESH: Extracellular Vesicles/metabolism
MESH: Signal Transduction/immunology
MESH: Toll-Like Receptor 3/immunology
viruses
MESH: Hepatitis C, Chronic/virology
MESH: Virus Replication/immunology
[SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunity
MESH: Humans
MESH: Extracellular Vesicles/immunology
MESH: Hepatitis C, Chronic/blood
MESH: Toll-Like Receptor 3/metabolism
Virology
MESH: Interferons/immunology
[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology
MESH: RNA, Double-Stranded/immunology
MESH: Host-Pathogen Interactions/immunology
MESH: RNA, Viral/isolation & purification
Źródło :
Gastroenterology, WB Saunders, 2018, 154 (8), pp.2237-2251.e16. ⟨10.1053/j.gastro.2018.03.020⟩
Tytuł :
PRO-C3:a new and more precise collagen marker for liver fibrosis in patients with chronic hepatitis C
Autorzy :
Hansen, Janne Fuglsang
Juul Nielsen, Mette
Nyström, Kristina
Leeming, Diana Julie
Lagging, Martin
Norkrans, Gunnar
Brehm Christensen, Peer
Karsdal, Morten
Pokaż więcej
Temat :
Journal Article
viral hepatitis
diagnostic tests
liver fibrosis
Chronic hepatitis C
non-invasive methods
Predictive Value of Tests
Enzyme-Linked Immunosorbent Assay
Area Under Curve
Humans
Middle Aged
Logistic Models
Male
Hepatitis C, Chronic/blood
Randomized Controlled Trials as Topic
Liver/pathology
Collagen Type III/blood
Liver Cirrhosis/diagnosis
Denmark
Adult
Biomarkers/blood
Female
Źródło :
Hansen, J F, Juul Nielsen, M, Nyström, K, Leeming, D J, Lagging, M, Norkrans, G, Brehm Christensen, P & Karsdal, M 2018, ' PRO-C3 : a new and more precise collagen marker for liver fibrosis in patients with chronic hepatitis C ', Scandinavian Journal of Gastroenterology, vol. 53, no. 1, pp. 83-87 . https://doi.org/10.1080/00365521.2017.1392596
Tytuł :
Secretion of Hepatitis C Virus Replication Intermediates Reduces Activation of Toll-Like Receptor 3 in Hepatocytes
Autorzy :
Grünvogel, Oliver
Colasanti, Ombretta
Lee, Ji-Young
Klöss, Volker
Belouzard, Sandrine
Reustle, Anna
Esser-Nobis, Katharina
Hesebeck-Brinckmann, Jasper
Mutz, Pascal
Hoffmann, Katrin
Mehrabi, Arianeb
Koschny, Ronald
Vondran, Florian W.R.
Gotthardt, Daniel
Schnitzler, Paul
Neumann-Haefelin, Christoph
Thimme, Robert
Binder, Marco
Bartenschlager, Ralf
Dubuisson, Jean
Dalpke, Alexander
Lohmann, Volker
Pokaż więcej
Temat :
Virology
Escape
Exosomes
Rab27a
MESH: Cell Line
MESH: Extracellular Vesicles/immunology
MESH: Hepacivirus/physiology
MESH: Hepatitis C, Chronic/blood
MESH: Humans
MESH: Hepatitis C, Chronic/immunology
MESH: Hepatitis C, Chronic/virology
MESH: Hepatocytes/immunology
MESH: Hepatocytes/metabolism
MESH: Host-Pathogen Interactions/immunology
MESH: Immunity, Innate
MESH: Interferons/immunology
MESH: RNA, Viral/immunology
MESH: Interferons/metabolism
MESH: Primary Cell Culture
MESH: RNA, Double-Stranded/immunology
MESH: RNA, Double-Stranded/isolation & purification
MESH: RNA, Double-Stranded/metabolism
MESH: RNA, Viral/isolation & purification
MESH: Extracellular Vesicles/metabolism
MESH: RNA, Viral/metabolism
MESH: Signal Transduction/immunology
MESH: Toll-Like Receptor 3/immunology
MESH: Toll-Like Receptor 3/metabolism
MESH: Virus Replication/immunology
[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology
[SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunity
[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology
Źródło :
Gastroenterology, WB Saunders, 2018, 154 (8), pp.2237-2251.e16. ⟨10.1053/j.gastro.2018.03.020⟩
Tytuł :
Secretion of Hepatitis C Virus Replication Intermediates Reduces Activation of Toll-Like Receptor 3 in Hepatocytes
Autorzy :
Grünvogel, Oliver
Colasanti, Ombretta
Lee, Ji-Young
Klöss, Volker
Belouzard, Sandrine
Reustle, Anna
Esser-Nobis, Katharina
Hesebeck-Brinckmann, Jasper
Mutz, Pascal
Hoffmann, Katrin
Mehrabi, Arianeb
Koschny, Ronald
Vondran, Florian W.R.
Gotthardt, Daniel
Schnitzler, Paul
Neumann-Haefelin, Christoph
Thimme, Robert
Binder, Marco
Bartenschlager, Ralf
Dubuisson, Jean
Dalpke, Alexander
Lohmann, Volker
Pokaż więcej
Temat :
Virology
Escape
Exosomes
Rab27a
MESH: Cell Line
MESH: Extracellular Vesicles/immunology
MESH: Hepacivirus/physiology
MESH: Hepatitis C, Chronic/blood
MESH: Humans
MESH: Hepatitis C, Chronic/immunology
MESH: Hepatitis C, Chronic/virology
MESH: Hepatocytes/immunology
MESH: Hepatocytes/metabolism
MESH: Host-Pathogen Interactions/immunology
MESH: Immunity, Innate
MESH: Interferons/immunology
MESH: RNA, Viral/immunology
MESH: Interferons/metabolism
MESH: Primary Cell Culture
MESH: RNA, Double-Stranded/immunology
MESH: RNA, Double-Stranded/isolation & purification
MESH: RNA, Double-Stranded/metabolism
MESH: RNA, Viral/isolation & purification
MESH: Extracellular Vesicles/metabolism
MESH: RNA, Viral/metabolism
MESH: Signal Transduction/immunology
MESH: Toll-Like Receptor 3/immunology
MESH: Toll-Like Receptor 3/metabolism
MESH: Virus Replication/immunology
[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology
[SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunity
[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology
Źródło :
Gastroenterology, WB Saunders, 2018, 154 (8), pp.2237-2251.e16. ⟨10.1053/j.gastro.2018.03.020⟩
Tytuł :
Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy
Autorzy :
Sultanik, Philippe
Mallet, Vincent
Lagaye, Sylvie
Casrouge, Armanda
Dorival, Céline
Barthe, Yoann
Fontaine, Hélène
Hézode, Christophe
Mottez, Estelle
Bronowicki, Jean-Pierre
Carrat, Fabrice
Theodorou, Ioannis
Abel, Laurent
Gayat, Etienne
Fontanet, Arnaud
Pol, Stanislas
Albert, Matthew L.
Pokaż więcej
Temat :
MESH: Drug Therapy, Combination
MESH : Proline/therapeutic use
MESH: Male
MESH: Treatment Outcome
MESH : Proline/analogs & derivatives
MESH: Ribavirin/therapeutic use
chronic hepatitis C
MESH: Proline/therapeutic use
MESH: Hepacivirus/genetics
MESH: Time Factors
MESH : Recombinant Proteins/therapeutic use
MESH : Hepacivirus/genetics
MESH : Male
MESH: Viral Nonstructural Proteins/metabolism
MESH : beta 2-Glycoprotein I/blood
MESH : Middle Aged
MESH: Predictive Value of Tests
MESH : Hepatitis C, Chronic/blood
MESH : Antiviral Agents/therapeutic use
HCV protease inhibitor
MESH : Biomarkers/blood
MESH: Female
apolipoprotein H
MESH : Treatment Outcome
MESH: Hepacivirus/enzymology
MESH: Protease Inhibitors/therapeutic use
MESH: Virus Replication/drug effects
MESH: beta 2-Glycoprotein I/blood
MESH: Hepacivirus/growth & development
MESH: Area Under Curve
MESH: Molecular Targeted Therapy
biomarker
MESH: Hepatitis C, Chronic/blood
MESH : Time Factors
MESH: RNA, Viral/blood
MESH: Biomarkers/blood
MESH: Antiviral Agents/therapeutic use
MESH : Oligopeptides/therapeutic use
MESH: Middle Aged
MESH : Humans
MESH: Hepacivirus/drug effects
virus diseases
MESH : Hepacivirus/enzymology
MESH : Aged
MESH: Viral Load
MESH : Viral Nonstructural Proteins/metabolism
MESH: Oligopeptides/therapeutic use
MESH: Aged
MESH : Viral Load
[SDV.IMM]Life Sciences [q-bio]/Immunology
MESH : Interferon-alpha/therapeutic use
MESH : Hepatitis C, Chronic/diagnosis
MESH: Interferon-alpha/therapeutic use
MESH: Hepatitis C, Chronic/diagnosis
MESH : Hepacivirus/growth & development
MESH : Prospective Studies
MESH: France
MESH : RNA, Viral/blood
MESH : ROC Curve
MESH : Female
MESH : France
MESH : Virus Replication/drug effects
MESH : Hepacivirus/drug effects
MESH : Ribavirin/therapeutic use
MESH: Hepatitis C, Chronic/drug therapy
MESH : Polyethylene Glycols/therapeutic use
MESH : Drug Therapy, Combination
MESH: Polyethylene Glycols/therapeutic use
MESH: Humans
MESH : Protease Inhibitors/therapeutic use
MESH : Molecular Targeted Therapy
digestive system diseases
MESH : Predictive Value of Tests
MESH: Prospective Studies
virological response
MESH: Proline/analogs & derivatives
MESH : Hepatitis C, Chronic/drug therapy
MESH: Viral Nonstructural Proteins/antagonists & inhibitors
MESH: ROC Curve
MESH: Recombinant Proteins/therapeutic use
[ SDV.IMM ] Life Sciences [q-bio]/Immunology
MESH : Area Under Curve
MESH : Viral Nonstructural Proteins/antagonists & inhibitors
Źródło :
Liver International, Wiley-Blackwell, 2015, 35 (7), pp.1833 - 1844. ⟨10.1111/liv.12759⟩
Liver International, Wiley-Blackwell, 2015, 35 (7), pp.1833 - 1844. 〈10.1111/liv.12759〉
Tytuł :
Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy
Autorzy :
Sultanik, Philippe
Mallet, Vincent
Lagaye, Sylvie
Casrouge, Armanda
Dorival, Céline
Barthe, Yoann
Fontaine, Hélène
Hézode, Christophe
Mottez, Estelle
Bronowicki, Jean-Pierre
Carrat, Fabrice
Theodorou, Ioannis
Abel, Laurent
Gayat, Etienne
Fontanet, Arnaud
Pol, Stanislas
Albert, Matthew L.
Pokaż więcej
Temat :
HCV protease inhibitor
apolipoprotein H
biomarker
chronic hepatitis C
virological response
MESH: Aged
MESH: Antiviral Agents/therapeutic use
MESH: Protease Inhibitors/therapeutic use
MESH: RNA, Viral/blood
MESH: Hepacivirus/growth & development
MESH: ROC Curve
MESH: Recombinant Proteins/therapeutic use
MESH: Ribavirin/therapeutic use
MESH: Biomarkers/blood
MESH: Time Factors
MESH: Treatment Outcome
MESH: Viral Load
MESH: Molecular Targeted Therapy
MESH: Viral Nonstructural Proteins/antagonists & inhibitors
MESH: Viral Nonstructural Proteins/metabolism
MESH: Virus Replication/drug effects
MESH: Hepatitis C, Chronic/blood
MESH: beta 2-Glycoprotein I/blood
MESH: Drug Therapy, Combination
MESH: Female
MESH: France
MESH: Hepacivirus/drug effects
MESH: Hepacivirus/enzymology
MESH: Oligopeptides/therapeutic use
MESH: Hepacivirus/genetics
MESH: Hepatitis C, Chronic/diagnosis
MESH: Hepatitis C, Chronic/drug therapy
MESH: Humans
MESH: Interferon-alpha/therapeutic use
MESH: Male
MESH: Middle Aged
MESH: Area Under Curve
MESH: Polyethylene Glycols/therapeutic use
MESH: Predictive Value of Tests
MESH: Proline/analogs & derivatives
MESH: Proline/therapeutic use
MESH: Prospective Studies
[SDV.IMM]Life Sciences [q-bio]/Immunology
Źródło :
Liver International, Wiley-Blackwell, 2015, 35 (7), pp.1833 - 1844. ⟨10.1111/liv.12759⟩
Tytuł :
Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy
Autorzy :
Sultanik, Philippe
Mallet, Vincent
Lagaye, Sylvie
Casrouge, Armanda
Dorival, Céline
Barthe, Yoann
Fontaine, Hélène
Hézode, Christophe
Mottez, Estelle
Bronowicki, Jean-Pierre
Carrat, Fabrice
Theodorou, Ioannis
Abel, Laurent
Gayat, Etienne
Fontanet, Arnaud
Pol, Stanislas
Albert, Matthew L.
Pokaż więcej
Temat :
HCV protease inhibitor
apolipoprotein H
biomarker
chronic hepatitis C
virological response
MESH: Aged
MESH: Antiviral Agents/therapeutic use
MESH: Protease Inhibitors/therapeutic use
MESH: RNA, Viral/blood
MESH: Hepacivirus/growth & development
MESH: ROC Curve
MESH: Recombinant Proteins/therapeutic use
MESH: Ribavirin/therapeutic use
MESH: Biomarkers/blood
MESH: Time Factors
MESH: Treatment Outcome
MESH: Viral Load
MESH: Molecular Targeted Therapy
MESH: Viral Nonstructural Proteins/antagonists & inhibitors
MESH: Viral Nonstructural Proteins/metabolism
MESH: Virus Replication/drug effects
MESH: Hepatitis C, Chronic/blood
MESH: beta 2-Glycoprotein I/blood
MESH: Drug Therapy, Combination
MESH: Female
MESH: France
MESH: Hepacivirus/drug effects
MESH: Hepacivirus/enzymology
MESH: Oligopeptides/therapeutic use
MESH: Hepacivirus/genetics
MESH: Hepatitis C, Chronic/diagnosis
MESH: Hepatitis C, Chronic/drug therapy
MESH: Humans
MESH: Interferon-alpha/therapeutic use
MESH: Male
MESH: Middle Aged
MESH: Area Under Curve
MESH: Polyethylene Glycols/therapeutic use
MESH: Predictive Value of Tests
MESH: Proline/analogs & derivatives
MESH: Proline/therapeutic use
MESH: Prospective Studies
[SDV.IMM]Life Sciences [q-bio]/Immunology
Źródło :
Liver International, Wiley-Blackwell, 2015, 35 (7), pp.1833 - 1844. ⟨10.1111/liv.12759⟩
Tytuł :
A lead-in with silibinin prior to triple-therapy translates into favorable treatment outcomes in difficult-to-treat HIV/Hepatitis C coinfected patients
Autorzy :
Braun, D.L.
Rauch, A.
Aouri, M.
Durisch, N.
Eberhard, N.
Anagnostopoulos, A.
Ledergerber, B.
Müllhaupt, B.
Metzner, K.J.
Decosterd, L.
Böni, J.
Weber, R.
Fehr, J.
Pokaż więcej
Temat :
Adult
Antiretroviral Therapy, Highly Active
Antiviral Agents/therapeutic use
Coinfection
Drug Administration Schedule
Female
HIV/drug effects
HIV/growth & development
HIV Infections/blood
HIV Infections/drug therapy
Hepacivirus/drug effects
Hepacivirus/growth & development
Hepatitis C, Chronic/blood
Hepatitis C, Chronic/drug therapy
Humans
Injections, Intravenous
Interferon-alpha/therapeutic use
Liver Cirrhosis/blood
Liver Cirrhosis/drug therapy
Male
Middle Aged
Oligopeptides/therapeutic use
Patient Safety
Polyethylene Glycols/therapeutic use
Prospective Studies
Protease Inhibitors/therapeutic use
RNA, Viral/antagonists & inhibitors
RNA, Viral/blood
Recombinant Proteins/therapeutic use
Ribavirin/therapeutic use
Silymarin/therapeutic use
Treatment Outcome
Viral Load/drug effects
Clinic for Infectious Diseases
Research Article
610 Medicine & health
virus diseases
digestive system diseases
Clinic for Gastroenterology and Hepatology
Źródło :
Braun, Dominique L; Rauch, Andri; Aouri, Manel; Durisch, Nina; Eberhard, Nadia; Anagnostopoulos, Alexia; Ledergerber, Bruno; Müllhaupt, Beat; Metzner, Karin J; Decosterd, Laurent; Böni, Jürg; Weber, Rainer; Fehr, Jan (2015). A lead-in with silibinin prior to triple-therapy translates into favorable treatment outcomes in difficult-to-treat HIV/Hepatitis C coinfected patients. PLoS ONE, 10(7):e0133028.
Plos One, vol. 10, no. 7, pp. e0133028
Opis pliku :
application/pdf
Tytuł :
Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study
Autorzy :
Kovari, Helen
Russmann, Stefan
Ledergerber, Bruno
Müller, Daniel
Rotger, Margalida
Velli, Pablo
Cavassini, Matthias
Ambrosioni, Juan
Bregenzer, Andrea
Stöckle, Marcel
Bernasconi, Enos
Rauch, Andri
Speck, Roberto F
Pokaż więcej
Temat :
Research Article
Adult
Antiviral Agents/therapeutic use
Coinfection/blood
Coinfection/complications
Drug Monitoring
Drug Therapy, Combination
Female
Follow-Up Studies
Genotype
HIV Infections/blood
HIV Infections/complications
HIV-1/drug effects
Hepacivirus/drug effects
Hepatitis C, Chronic/blood
Hepatitis C, Chronic/complications
Humans
Interferon-alpha/therapeutic use
Male
Middle Aged
Polyethylene Glycols/therapeutic use
Prospective Studies
Recombinant Proteins/therapeutic use
Ribavirin/blood
Ribavirin/therapeutic use
Treatment Outcome
610 Medicine & health
virus diseases
digestive system diseases
Źródło :
Plos One, vol. 10, no. 7, pp. e0133879
Kovari, Helen; Russmann, Stefan; Ledergerber, Bruno; Müller, Daniel; Rotger, Margalida; Velli, Pablo; Cavassini, Matthias; Ambrosioni, Juan; Bregenzer, Andrea; Stöckle, Marcel; Bernasconi, Enos; Rauch, Andri; Speck, Roberto F (2015). Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study. PLoS ONE, 10(7), e0133879. Public Library of Science 10.1371/journal.pone.0133879
Opis pliku :
application/pdf
Tytuł :
Discrimination of agonist and antagonist forms of CXCL10 in biological samples
Autorzy :
Casrouge, A
Bisiaux, A
Stephen, L
Schmolz, M
Mapes, J
Pfister, C
Pol, S
Mallet, V
Albert, M L
Pokaż więcej
Temat :
MESH : Immunoenzyme Techniques/methods
MESH: Male
MESH: Antibodies, Monoclonal/immunology
MESH : Peptide Fragments/immunology
MESH: Chemokine CXCL10/immunology
MESH : Male
MESH: Immunoenzyme Techniques/methods
MESH : Middle Aged
MESH : Chemokine CXCL10/analysis
bladder cancer
MESH : Hepatitis C, Chronic/blood
MESH : Chemokine CXCL10/immunology
MESH: Female
MESH: Protein Isoforms/analysis
MESH: Adult
MESH: Dipeptidyl Peptidase 4/metabolism
MESH : Protein Structure, Tertiary
MESH : Protein Isoforms/analysis
MESH : Body Fluids/chemistry
MESH : Enzyme-Linked Immunosorbent Assay/methods
MESH: Hepatitis C, Chronic/blood
hepatitis C virus
MESH: Biomarkers
MESH : Protein Isoforms/immunology
MESH: Peptide Fragments/immunology
MESH : Dipeptidyl Peptidase 4/metabolism
MESH: Middle Aged
MESH : Adult
MESH : Humans
MESH: Enzyme-Linked Immunosorbent Assay/methods
MESH : Aged
MESH : Antibodies, Monoclonal/immunology
MESH : Aged, 80 and over
chemokines/monokines
MESH: Culture Media, Conditioned/chemistry
MESH: Inflammation
MESH: Aged
MESH: Aged, 80 and over
[SDV.IMM]Life Sciences [q-bio]/Immunology
BCG
MESH : Culture Media, Conditioned/chemistry
MESH : Recombinant Fusion Proteins/analysis
MESH : Female
Translational Studies
MESH : Inflammation
MESH : Protein Processing, Post-Translational
MESH: Peptide Fragments/analysis
MESH : Neoplasm Proteins/urine
MESH: Chemokine CXCL10/analysis
MESH : Urinary Bladder Neoplasms/urine
MESH: Body Fluids/chemistry
MESH: Humans
MESH: Neoplasm Proteins/urine
MESH: Protein Structure, Tertiary
MESH : Carcinoma, Transitional Cell/urine
MESH: Protein Isoforms/immunology
MESH : Biomarkers
MESH: Carcinoma, Transitional Cell/urine
MESH : Peptide Fragments/analysis
MESH: Recombinant Fusion Proteins/analysis
MESH: Urinary Bladder Neoplasms/urine
MESH: Protein Processing, Post-Translational
[ SDV.IMM ] Life Sciences [q-bio]/Immunology
Źródło :
Clinical and Experimental Immunology
Clinical and Experimental Immunology, Wiley, 2012, 167 (1), pp.137 - 148. 〈10.1111/j.1365-2249.2011.04488.x〉
Clinical and Experimental Immunology, Wiley, 2012, 167 (1), pp.137 - 148. ⟨10.1111/j.1365-2249.2011.04488.x⟩
Tytuł :
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV.
Autorzy :
Casrouge, Armanda
Decalf, Jérémie
Ahloulay, Mina
Lababidi, Cyril
Mansour, Hala
Vallet-Pichard, Anaïs
Mallet, Vincent
Mottez, Estelle
Mapes, James
Fontanet, Arnaud
Pol, Stanislas
Albert, Matthew L.
Pokaż więcej
Temat :
MESH : T-Lymphocytes/immunology
MESH: Dipeptidyl Peptidase 4/blood
MESH : Prognosis
Research Article
MESH: Ribavirin/therapeutic use
[SDV.IMM]Life Sciences [q-bio]/Immunology
MESH : Hepatitis C, Chronic/therapy
MESH : Interferon-alpha/therapeutic use
MESH : Chemokine CXCL10/blood
MESH : Antiviral Agents/therapeutic use
MESH: Treatment Failure
MESH: Interferon-alpha/therapeutic use
MESH : Protein Array Analysis
MESH: Recombinant Proteins
MESH : Hepatitis C, Chronic/virology
MESH: Hepatitis C, Chronic/therapy
MESH : Hepatitis C, Chronic/blood
MESH: T-Lymphocytes/virology
MESH : Hepatitis C, Chronic/immunology
MESH: Hepatitis C, Chronic/immunology
MESH: Receptors, CXCR3/blood
MESH : Ribavirin/therapeutic use
MESH : T-Lymphocytes/virology
MESH : Polyethylene Glycols/therapeutic use
MESH: Protein Array Analysis
MESH: Antiviral Agents/therapeutic use
MESH: Chemokine CXCL10/antagonists & inhibitors
MESH : Chemokine CXCL10/antagonists & inhibitors
MESH : Recombinant Proteins
MESH: Hepatitis C, Chronic/virology
MESH: Polyethylene Glycols/therapeutic use
MESH: Chemokine CXCL10/blood
MESH: T-Lymphocytes/immunology
MESH: Humans
MESH : Dipeptidyl Peptidase 4/blood
MESH: Hepatitis C, Chronic/blood
MESH: Prognosis
MESH : Treatment Failure
MESH : Receptors, CXCR3/blood
MESH: Peptide Fragments/blood
MESH : Peptide Fragments/blood
MESH : Humans
virus diseases
[ SDV.IMM ] Life Sciences [q-bio]/Immunology
Źródło :
Journal of Clinical Investigation
Journal of Clinical Investigation, American Society for Clinical Investigation, 2011, 121 (1), pp.308-17. ⟨10.1172/JCI40594⟩
Journal of Clinical Investigation, American Society for Clinical Investigation, 2011, 121 (1), pp.308-17. 〈10.1172/JCI40594〉
    Wyświetlanie 1-15 z 15

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies